ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01856478
Brief Title: LUX-Head&Neck 3: Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

First Submitted : May 15, 2013
First Submitted that Met QC Criteria : May 15, 2013
First Posted : May 17, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : October 16, 2018
Last Update Posted : October 18, 2018